CORVAL

Live / Registered — Registered (as of 13 Sept 2022)

What this means for you

Registered since 13 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90046504
Registration number
6847326
Mark type
Design + words
Filed
10 Jul 2020
Published for opposition
14 Sept 2021
Registered
13 Sept 2022
Attorney of record
Miguel Danielson

Goods and services

  • Class 035 — Advertising and business services: Business consulting services in the fields of life sciences and biotechnology, namely, providing business planning and strategy services to manufacturers relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease; Business consulting services in the fields of life sciences and biotechnology, namely, providing business strategic planning roadmaps to manufacturers to inform business planning, identify objectives and track activities relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease
  • Class 042 — Scientific and technological services: Providing software as a service (SaaS), namely, non-downloadable web-based software for use by manufacturers in the fields of life sciences and pharmaceuticals for facilitating and streamlining the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease; Providing collaborative planning and technology solutions to manufacturers in the fields of life sciences and pharmaceuticals, namely, providing online non-downloadable web-based software for cloud-based collaboration and strategic planning relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease; Development and implementation of collaborative planning and technology solutions for use by manufacturers in the fields of life sciences and pharmaceuticals, namely, development and implementation of web-based software that enables users to connect and collaborate with each other to plan business and market entry strategies relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease

Owner

Prosecution history

  • 13 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 13 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
  • 09 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 08 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 20 Jul 2022 — STATEMENT OF USE PROCESSING COMPLETE
  • 01 Jul 2022 — USE AMENDMENT FILED
  • 20 Jul 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 01 Jul 2022 — TEAS STATEMENT OF USE RECEIVED
  • 11 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 09 May 2022 — SOU EXTENSION 1 GRANTED
  • 09 May 2022 — SOU EXTENSION 1 FILED
  • 09 May 2022 — SOU TEAS EXTENSION RECEIVED
  • 09 Nov 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 14 Sept 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 14 Sept 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

View this trademark record on Marksy